PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Pharm Exec’s Brand of the Year 2016

Any Chance for “Cures” Legislation This Year?

Interview: GSK’s Jack Bailey

Europe

Brexit and UK Pharma

Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the European Union
... /Read more/

Considering changing product access vendors? Watch this brief video to learn an effective 4-point methodology to optimize your program transition by addressing data conversion, implementation planning, stakeholder communications, and technology.

Learn more

Europe

Europe’s “Radical” Regulators Drawn into Pricing Debate

Radicals who wield real power at the agency went public with their latest thinking about the role of regulators in the economic aspects of medicines provision – despite the decades-old European Union taboo about linking pricing with authorizations.
... /Read more/

Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
Live Webinar: Tuesday, June 7, 2016 at 1-2 pm EDT

Free registration

Europe

NICE Lite?

Is a more "light-touch" appraisal process the key to getting the UK’s NICE to do more with less? Leela Barham reports
... /Read more/

Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST

Free registration

Antimicrobial Drugs

The UK Pay-or-Play Solution: A Horribly Flawed Idea

We desperately need new anti-infective drugs to avoid life threatening infections. Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs, writes Ed Schoonveld
... /Read more/

Strategic considerations for clinical development programs in emerging biopharma companies
On Demand

Learn more

Calendar

/ June 6–9: BIO International Convention /

San Francisco, CA.

/ June 21–22: Patient Engagement Solutions Summit /

Philadelphia, PA.

/ June 22–23: Global Medical Information and Communications Summit /

Barcelona, Spain.

/ June 23–24: Bio/Pharma Product Forecasting Summit /

Philadelphia, PA.

/ August 15–17: 10^th Annual Forum on Transparency and Aggregate Spend /

Washington, DC.

/ December 13–14: Life Sciences Trade and Channel Strategies /

Philadelphia, PA

Understanding the Chronic Disease Patient Journey in Emerging Markets
On Demand

Learn more

Precision asset valuation Leveraging insights from clinical and market access big data
On Demand

Learn more

Industry update

//Sanofi (Paris, France) announced the departure of three of its top executives: Pascale Witz, Executive Vice President of Diabetes and Cardiovascular; Carsten Hellmann, Executive Vice President of Merial, Sanofi’s animal health division; and Suresh Kumar, Executive Vice President of External Affairs. Hellmann has been appointed President and CEO of ALK (Horsholm, Denmark).//Cytokinetics, Inc. (South San Francisco, CA) appointed Edward M. Kaye, M.D., to the company’s Board of Directors.//Envigo (Huntingdon, UK) announced the appointment of Scott Schulz, MBA, to the post of Director, North American (NA) Operations.//

Medical science liaisons Optimizing their impact during product launch
On Demand

Learn more

advertise with us / print subscribe / digital subscribe / visit pharmexec.com